PT-141 (Bremelanotide) is a research peptide that acts as a melanocortin receptor agonist, specifically targeting MC-1R and MC-4R receptors. This research-grade compound is synthesized to the highest purity standards (99%+) and undergoes rigorous third-party testing for quality assurance.